University of Cincinnati College of Medicine - 231 Albert Sabin Way is a clinical research site located in Cincinnati, Ohio, United States 45267-2827.
Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.
University of Cincinnati College of Medicine - 231 Albert Sabin Way has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: IgA Nephropathy, Immunoglobulin A Nephropathy.
Sponsors: Novartis Pharmaceuticals.
Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of Cincinnati College of Medicine - 231 Albert Sabin Way has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Cincinnati College of Medicine - 231 Albert Sabin Way has 1 clinical trials on record, with 1 currently active. Their work covers IgA Nephropathy, Immunoglobulin A Nephropathy.
University of Cincinnati College of Medicine - 231 Albert Sabin Way has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.